ANIK financials
Anika Therapeutics (ANIK) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- ANIK revenue was $112.82M in fiscal 2025, net income -$10.88M.
ANIK income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $112.82M | $63.81M | -$11.05M | -$10.88M | -0.76 |
| 2024 | $119.91M | $76.00M | -$5.10M | -$56.38M | -3.83 |
| 2023 | $120.79M | $82.53M | $844.00K | -$82.67M | -5.64 |
| 2022 | $113.83M | $73.22M | $3.67M | -$14.86M | -1.02 |
| 2021 | $147.79M | $82.94M | $2.62M | $4.13M | 0.28 |
| 2020 | $130.46M | $69.03M | -$28.32M | -$23.98M | -1.69 |